Vital Signs - A Year in Action: How has the Financial Crisis Affected Spending on Medical Imaging Technology in the United States?

 

Regular Price: USD 1,500

Special Price USD 1,050

30% OFF

* Required Fields

Regular Price: USD 1,500

Special Price USD 1,050

PAY BY INVOICE

Be the first to review this product

This issue of Vital Signs, released on July 12, 2010, provides a strategic analysis of the impact of the financial crisis on medical imaging technology spending in the U.S. As part of this, the article presents related feedback from key U.S. decision makers (N=103) of medical imaging technology purchasing. Additionally, a company spotlight is provided for VisEn Medical, a company focused on in vivo imaging solutions. Reimbursement and regulatory news from the FDA is also provided for the week of June 21, 2010.

Table of Contents

Vital Signs - A Year in Action: How has the Financial Crisis Affected Spending on Medical Imaging Technology in the United States?Vital Signs: 12 July 2010This week's issue:




Related Research

Release Date : 19-Sep-17

Region : North America

Release Date : 08-Sep-17

Region : North America

Release Date : 22-Aug-17

Region : North America

Release Date : 08-Aug-17

Region : North America

Release Date : 31-Jul-17

Region : North America

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.